Replies to post #194408 on Innovation Pharmaceuticals Inc (IPIX)

[frrol]

I too did M&A work, and it's funny how you can do the most sophisticated NPV analysis that takes twenty Excel tabs, but the deal usually ends up relying on a simple EBITDA or projected sales multiple, because that's what the BOD's understand.

With biotech, NPV is not really feasible or sensible. You go with a multiple of projected sakes.